Chinese Journal of Osteoporosis · Nov 12, 2026
Association between UHR and sarcopenia in older adults in agricultural and pastoral areas of Xinjiang
By 王安彦
OBJECTIVE: To investigate the relationship between the serum uric acid (sUA) to high-density lipoprotein cholesterol (HDL-C) ratio (UHR) and sarcopenia in community-dwelling older adults in Xinjiang. METHODS: Data were selected from the database of the June 2024 follow-up of the Xinjiang Longitudinal Aging Cohort (ChiCTR2400093292), and a total of 476 older adults (65 years and older) were included. Differences and correlations in grip strength, gait speed, appendicular skeletal muscle mass (ASM), and the ratio of appendicular skeletal muscle mass to body weight (SMI) across UHR groups were analyzed. Logistic regression models were used to assess the relationship between UHR and sarcopenia, and receiver operating characteristic (ROC) curve analysis was used to assess the predictive value of UHR for sarcopenia. RESULTS: Mean ASM, SMI, and grip strength increased with increasing UHR (P<0.05). General linear model analysis showed that UHR (Q3–Q4 groups) was positively correlated with grip strength (β=2.064) and SMI (Q3 β=0.693, Q4 β=0.911) (P<0.05), and declining muscle function was positively correlated with increasing age and female sex (P<0.05). Logistic regression analysis suggested that, after adjustment for confounding factors including BMI, HCY, Cys-C, age, sex, smoking, and alcohol consumption, high UHR levels (Q3–Q4 quartile groups) were associated with a reduced risk of sarcopenia (Q3: OR=0.257, 95%CI: 0.108–0.612; Q4: OR=0.238, 95%CI: 0.092–0.616; all P≤0.003); moderate UHR levels in the Q2 group (OR=0.605, P=0.167) and UHR as a continuous variable (OR=0.997, P=0.050) were not statistically significant after adjustment for BMI. ROC analysis showed that UHR had moderate ability to predict sarcopenia, with an AUC of 0.639 (95%CI: 0.570–0.708). CONCLUSIONS: Elevated UHR may be a protective factor for muscle mass and strength. The protective effect of high UHR (Q3–Q4 groups) against sarcopenia was stable and independent of BMI and metabolic factors such as HCY and Cys-C.